🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Georgia

Etid klinik pou Dyabèt Tip 2 nan Georgia

34 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Georgia.

Vil nan Georgia

Tèks ofisyèl etid la (Anglè)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Centricity Research, Endocrine Consultants, Columbus
  • Javara-Fayetteville-67354, Fayetteville
  • Balanced Life Health Care Solutions, Lawrenceville
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Centricity Research, Endocrine Consultants, Columbus
  • NSC Research Inc, Johns Creek
  • The Jones Center Clinical Research, LLC, Macon
  • ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • North Georgia Clinical Research, Woodstock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Aiyan Diabetes Center, Augusta
  • Emory University, Dunwoody
  • Privia Medical Group Georgia LLC -Fayetteville (Javara), Fayetteville
  • ak 7 plis
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • The Jones Center Clinical Research, Macon
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Woodstock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Canton
  • AURORA-2 Clinical Site, Decatur
  • AURORA-2 Clinical Site, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Privia Medical Group Georgia, LLC - Albany - Javara - PPDS, Albany
  • Javara Inc. - Fayetteville, Fayetteville
  • Privia Medical Group Georgia, LLC - Savannah - Javara - PPDS, Savannah
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centricity Research Columbus Georgia Multispecialty, Columbus
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
  • Physicians Research Associates, Lawrenceville
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Privia Medical Group of Georgia, LLC, Savannah
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Columbus Research Foundation, Columbus
  • Eastside Bariatric and Gen Surg, Snellville
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Emory University School of Medicine, Atlanta
  • IACT Health-Brookstone Centre Pkwy, Columbus
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • SKY Clinical Research Network Group-Brown, Atlanta
  • Teak Research Consults, Lawrenceville
  • AGILE Clinical Research Trials, LLC, Sandy Springs
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

  • Georgia State University, Atlanta
Ap rekrite
Laj 20 a 65 · Fanm · Mizajou Sep 2, 2026 · NCT06735651

Peanuts for Cardiometabolic, Brain, and Intestinal Health

  • Georgia State University, Atlanta
Ap rekrite
Laj 20 a 59 · Tout sèks · Mizajou Sep 2, 2026 · NCT06867198

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Javara/Privia Med Grp GA,LLC, Albany
  • David Kavtaradze MD, Inc., Cordele
  • Atlanta Heart Specialist, Tucker
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Conyers
  • Research Site, Decatur
  • Research Site, Hinesville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Atlanta
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Decatur
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Centricity Research IRT - DBA IACT Health Columbus Piedmont, Columbus
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management

  • Emory Healthcare, Atlanta
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07474376

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
  • Centricity Research Columbus Endocrinology, Columbus
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

Families Implementing Good Health Traditions for Life

  • Morehouse School of Medicine, Albany
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07441655

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • EMORY, Atlanta
  • Atlanta Diabetes Associates, Atlanta
  • Endocrine Research Solutions, Inc., Rosewell
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Emory University, Atlanta
Ap rekrite
Laj 14 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07579702

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

  • Grady Memorial Hospital, Atlanta
Ap rekriteFaz 3
Laj 65 ak plis · Fanm · Mizajou Aug 3, 2026 · NCT07428746

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT06699810

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • David Kavtaradze MD, Inc, Cordele
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • David Kavtaradze MD InC, Cordele
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Mobile App Logging for Diabetes in Pregnancy

  • Augusta University, Augusta
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Fanm · Mizajou Jan 31, 2025 · NCT06005987

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.